Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 13, 2025, titled "Closure of USFDA inspection at Zydus formulation manufacturing plant at SEZ II, Ahmedabad".
Press Release Aug 13 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
In the deck
Earlier from Zydus Lifesciences
- Press Release Aug 12 2025
- Press Release Aug 11 2025
- Press Release Aug 08 2025
- Press Release Aug 07 2025
- Press Release Jul 29 2025
Later from Zydus Lifesciences
- Press Release 20-08-2025 Newspaperadvertisement20082025
- Zydus Therapeutics Reports Positive Topline Results from EPICS-III Phase 2(b)/3 Trial of Saroglitazar Magnesium in Patients with Primary Biliary Cholangitis
- Press Release Aug 29 2025
- Press Release Sep 02 2025
- Zydus and Synthon entered into exclusive licensing and supply agreement for Ozanimod Capsules (generic version of ZEPOSIA®) for the U.S. market
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences